507
rank
🔬 Science

Psychedelic Science

The renaissance of psychedelic research — psilocybin, MDMA, and ketamine transforming psychiatry.

📖 1 min read#507 rank
Share:WhatsAppX

About

Psychedelic research, suppressed after the 1970s drug laws, has experienced a remarkable renaissance. Clinical trials at Johns Hopkins, Imperial College London, and NYU have demonstrated that psilocybin (magic mushrooms) produces rapid and sustained improvements in treatment-resistant depression, end-of-life anxiety, PTSD, and addiction — effects lasting months from a single dose. MDMA-assisted therapy for PTSD has shown 67% remission rates in clinical trials — compared to 32% for therapy alone. The FDA granted MDMA 'Breakthrough Therapy' designation. Ketamine (and its derivative esketamine/Spravato) is FDA-approved for treatment-resistant depression. LSD research at Imperial College has shown promise for addiction treatment. These compounds appear to work by temporarily disrupting the default mode network — the brain's 'ego' circuitry.

# Top 10 psychedelic therapies

  1. 1psilocybin for depression
  2. 2MDMA for PTSD
  3. 3ketamine for depression
  4. 4ayahuasca for addiction
  5. 5LSD microdosing for creativity
  6. 6ibogaine for opioid addiction
  7. 75-MeO-DMT for anxiety
  8. 8psilocybin for end-of-life anxiety
  9. 9mescaline research
  10. 10MDMA for couples therapy

Fascinating Facts

  • Psilocybin therapy for depression produces improvements lasting months from a single dose — no daily medication required
  • MDMA-assisted therapy achieves 67% PTSD remission — compared to 32% with therapy alone
  • LSD was discovered accidentally in 1943 by Albert Hofmann, who synthesized it and then accidentally absorbed it through his fingertips
More in Science4 related